A range of preclinical and clinical studies are uncovering some of the unique properties and therapeutic potential of delta-8-THC
Pain and inflammation
A recent study published in Cannabis and Cannabinoid Research found that delta-8-THC may help to diminish pain and inflammation in corneal injury in mice. The research found that delta-8-THC, applied topically, assisted in pain reduction, and reduced inflammation through its effects on the CB1 receptors. Another preclinical study on rats reported that delta-8-THC delivers pain relief, but that tolerance to the cannabinoid developed rapidly.
The National Library of Medicine reports that delta-8-THC displays anxiety-reducing qualities similar to delta-9-THC. Anecdotal reports claim that the consumption of delta-8-THC results in a calm, focused high, but we need more clinical research into its anti-anxiety potential before drawing any conclusions.
The nausea-fighting potential of delta-8 THC was reported in a 1995 study published in Life Sciences. The study followed eight pediatric cancer patients over two years and found that no vomiting occurred when they ingested the compound before and for 24 hours after cancer treatment. as well as very few side effects. The study reported very few side effects.
Lose of appetite
Delta-8-THC may also help stimulate the appetite. Research conducted on mice and published in 2004 in Pharmacology, Biochemistry and Behavior found that a low dose of delta-8-THC administered to mice over 50 days resulted in a 22% increase in food intake compared with controls. The research also reported that delta-8-THC increased food intake significantly more than delta-9-THC, a known appetite stimulant.